'''Spiramide''' (developmental code name '''AMI-193''') is an experimental [[antipsychotic]] that acts as a [[binding selectivity|selective]] [[5-HT2A|5-HT<sub>2A</sub>]], [[5-HT1A|5-HT<sub>1A</sub>]], and [[D2 receptor|D<sub>2</sub>]] [[receptor (biochemistry)|receptor]] [[receptor antagonist|antagonist]]. It has negligible [[affinity (pharmacology)|affinity]] for the [[5-HT2C|5-HT<sub>2C</sub> receptor]].<ref name="pmid11124389">{{cite journal |vauthors=Czoty PW, Howell LL |title=Behavioral effects of AMI-193, a 5-HT(2A)- and dopamine D(2)-receptor antagonist, in the squirrel monkey |journal=Pharmacology, Biochemistry, and Behavior |volume=67 |issue=2 |pages=257–64 |date=October 2000 |pmid=11124389 |doi= 10.1016/S0091-3057(00)00321-X|url=}}</ref><ref name="pmid15610924">{{cite journal |vauthors=Luparini MR, Garrone B, Pazzagli M, Pinza M, Pepeu G |title=A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone |journal=Progress in Neuro-psychopharmacology & Biological Psychiatry |volume=28 |issue=7 |pages=1117–27 |date=November 2004 |pmid=15610924 |doi=10.1016/j.pnpbp.2004.05.046 |url=}}</ref><ref name="pmid17965538">{{cite journal |vauthors=Hamada K, Yoshida M, Isayama H, Yagi Y, Kanazashi S, Kashihara Y, Takeuchi K, Yamaguchi I |title=Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice |journal=Journal of Pharmacological Sciences |volume=105 |issue=3 |pages=240–50 |date=November 2007 |pmid=17965538 |doi= 10.1254/jphs.FP0071049|url=}}</ref>
